Related Experiment Video
Updated: May 21, 2026

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
Published on: June 5, 2020
[Hepatitis C viruses infection situation in the human population of six provinces in China]
Jian Lu1, Yu-qing Jiang, Hong-lan Zhao
1National Institute for Viral Disease Control and Prevention, China CDC, Beijing 100052, China.
Insights
Hepatitis C virus (HCV) seroprevalence in China ranged from 0.1% to 0.74%, with higher rates observed in individuals over 50 years old. Co-infections with Hepatitis A, E, and B viruses were also noted.
Area of Science:
- Virology
- Epidemiology
- Public Health
Context:
- Hepatitis C virus (HCV) infection poses a significant global health challenge.
- Understanding regional seroprevalence is crucial for targeted public health interventions.
- China, with its large population, requires detailed epidemiological data on viral hepatitis.
Purpose:
- To determine the seroprevalence of Hepatitis C virus (HCV) infection across six diverse regions in China.
- To analyze the demographic distribution of HCV infection, including age and sex.
- To investigate the co-occurrence of HCV with other viral hepatitis infections (HAV, HEV, HBV).
Summary:
- A total of 9,538 serum samples were analyzed using ELISA between 2006-2008.
- The overall anti-HCV IgG positive rate was 0.39%, varying from 0.1% in Ningxia to 0.74% in Heilongjiang.
- HCV infection was most prevalent in the population aged 50 and above (32.43%), and co-infections with Hepatitis A virus (HAV) were common (94.59%).
Impact:
- Provides essential data for the Chinese Ministry of Health to strategize HCV control programs.
- Highlights the importance of age-specific screening and prevention efforts for HCV.
- Informs clinical practice regarding the management of patients with co-existing viral hepatitis infections.
Objective:
To investigate the seroprevalence of hepatitis C viruse infection in the human population in six regions of Beijing, Heilongjiang, Shandong, Ningxia, Gansu and Sichuan in China.
Methods:
ELISA was used for detecting anti-HCV IgG of the serum samples. All sample were collected in 2006-2008 in six areas.
Results:
9538 samples were detected. The total positive rate of anti-HCV was 0.39% (37), 0.23% (3/1328) in Beijing, 0.74% (12/1629) in Heilongjiang, 0.26% (5/1962) in Shandong, 0.1% (1/1000) in Ningxia, 0.44% in Gansu (9/2 037) and Sichuan (7/1582), respectively. The 37 positive samples at the sex were 19 (51.35%) of man and 18 (48.65%) of female. At the age group were 1 (2.70%) of < 10 years old, 5 (13.51%) of 10-19 years old, 4 (10.81%) of 20-29 years old, 6 (16.22% ) of 30-39 years old, 9 (24.32%) of 4049 years old, 12 (32.43%) of > or = 50 years old. The positive samples were detected anti-HAV-IgG, anti-HEV-IgG and HBsAg/ HBcAb /HBeAb. The positive Number was 35 (94.59%), 10 (27.03%) and 2 (5.41%) respectively.
Conclusions:
HCV infection rate in the population was 0.1% -0.74%, 1/3 of > or = 50 years old in HCV positive. Hepatitis C virus co-infection with HAV, HEV and HBV.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Single Nucleotide Polymorphisms-SNPs
Cytomegalovirus Disease

